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A prevailing and persistent subject of controversy in immunology is whether 
the mechanism of immune tolerance to self antigens involves active, cell-mediated 
regulatory processes or is effected centrally and directly via interactions between 
antigen  and  effector  cell  precursors  (e.g.,  1-7).  The  debate  continues  to  be 
fueled by evidence for both regulatory (7) and direct mechanisms (8, 9) in similar 
systems.  Many  investigators  now  believe  that  multiple pathways  lead  to  self- 
tolerance, forming a web of failsafe mechanisms against autoimmunity (4, 5). 
The mechanism of T  cell tolerance has been especially difficult to approach 
because of our limited understanding of (a) antigen recognition by T  ceils, (b) 
the complex T  cell regulatory circuitry, and (c) the molecular and physiological 
basis for antigen-specific, T  cell-mediated suppression (i.e., the nature of the off 
signal,  half-life of clonal  inactivation,  reversibility,  target  cell death).  Conven- 
tional approaches to the question of whether tolerance is mediated by suppressor 
T  lymphocytes (Ts) 1 or through direct clonal inactivation by antigen have relied 
upon attempts to demonstrate Ts by in vitro cell mixing experiments or in vivo 
adoptive transfers.  However, recent work by several groups has demonstrated 
many intricate cellular requirements of T  cell-mediated suppression (e.g., mul- 
tiple interacting Ts subsets, distinct levels of suppression) (10, 11), and the several 
cellular activities that  may mask T  cell  suppression (e.g.,  augmenting T  cells, 
multiple subsets  of contrasuppressor T  cells) (11,  12).  The simple inability  to 
demonstrate active  suppression  is  not evidence  for  clonal  deletion,  and,  con- 
versely, the mere demonstration of active suppression does not rule out the role 
of clonal deletion mechanisms in tolerance. 
Recent work in several  laboratories  has demonstrated that cytotoxic T  lym- 
phocyte (CTL) precursor frequency, determined by limiting dilution analysis, is 
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dramatically lowered in mice neonatally tolerized for either major histocompat- 
ibility complex (MHC) (13,  14), virus (15), or hapten-conjugated  self-responses 
(16). Precursor frequencies of allo-MHC-specific, interleukin  2-producing cells 
are also dramatically  lowered in neonatally tolerized mice (14).  These findings 
are  an  important  demonstration  that  CTL  clonal  nonresponsiveness  can  be 
manifest in the short-term absence of Ts cells. However, lower CTL precursor 
frequencies may occur through  clonal paralysis or death, reflecting the mecha- 
nism of Ts action.  Recent work by Huerer et al.  (17) has demonstrated  that a 
cloned Ts cell can lyse antigen-specific target T  cells. 
Even less is known about tolerance of protein antigen-specific T  helper (Th) 
or proliferating (Tp) cells. The lack of a primary in vitro single-cell assay prevents 
the quantitation  of Th/p,  relatively free of Ts regulation,  by limiting  dilution 
assay. The recent demonstration, by Lamb et al. (18), of in vitro inactivation of 
human  T  cell  clones,  specific  for  influenza  hemagglutinin,  by high  doses  of 
hemagglutinin  peptides, indicates that deletion/anergy mechanisms are possible 
for  proliferating  Th  cell  clones.  However,  the  difficulty of tolerizing  human 
gamma globulin (HGG)-primed T  cells in vivo with doses of deaggregated HGG 
that inactivate HGG-specific naive T  cells, as well as primed or unprimed B cells 
(19), suggests that these findings should not yet be generalized to in vivo T  cell 
tolerance. 
The approach outlined in this paper is based on previous work in this laboratory 
and others showing that the specificities of Th and Ts cells are nonoverlapping 
in  the protein antigen  systems that  have been examined (20).  In the C57BL/6 
stain, which is nonresponsive to hen (chicken) eggwhite lysozyme (HEL), Ts cells 
are  restricted  to  the  recognition  of an  amino-terminal  epitope,  while antigen- 
specific Ts and  Tp cells are restricted  to "internal"  epitopes.  "Amputation"  of 
the Ts-inducing epitope from the rest of the molecule reveals the latent capacity 
to induce Tp or Th cell response by freeing these cells from Ts regulation (21- 
23).  It  is  thereby  possible  to  determine  whether  antigen-specific  Tp  remain 
responsive in  a  tolerant  animal  without precursor  frequency analysis,  by using 
peptide probes that lack Ts-inducing determinants (SD). 
In  this  report,  the amputation  approach  clearly indicates  that  in  acute,  low 
dose tolerance of adult responder strain B 10.A mice, proliferative HEL-specific 
T  cells are regulated by an active mechanism, presumably mediated by Ts cells. 
Two other states of tolerance were examined:  neonatal  tolerance,  after which 
HEL-specific T  cells were not responsive to the  available peptide probes; and 
high dose adult tolerance, in which T  cells of discrete specificities were affected 
differentially.  Whether  functional  clonal  deletion  had  taken  place,  and/or 
whether the activation of usually quiescent Ts with specificity for SD within the 
peptide  probes  used  for  challenge  had  occurred,  awaits  critical  analysis  with 
minimal peptide determinants that are small enough to exclude SD. 
Materials and Methods 
Animals.  B10.A  mice  were  bred  from  mating  pairs  purchased  from  The Jackson 
Laboratory,  Bar  Harbor,  ME,  and  raised  in  the  vivarium  facility maintained  by this 
laboratory. Mice of both sexes were used at 8-24 wk of age for all experiments. 
Antigens.  HEL was obtained from Societa Prodotti Antibiotici  (Milan, Italy) and was 
chromatographed  before use  on  Biorex  70  (Bio-Rad  Laboratories,  Richmond,  CA) as 
previously described (22). Detailed  preparation and characterization  of NC (22), amino- 
peptidase-treated HEL (AP-HEL) (23), L2, and L3 (24), are given elsewhere: a summary 
appears in Fig. 1. OKI  AND  SERCARZ  899 
Acute Adult Tolerance (A-TOL) Induction.  8-24-wk-old B10.A mice were administered 
2 mg of HEL [A-TOL(2 mg)] dissolved in 0.2 ml of normal saline, or 20 mg of HEL [A- 
TOL(20 mg)] in 0.2 ml aqueous solution by retroorbital injection. Control mice received 
normal saline.  Mice were rested 10-14 d before in vivo immunization. 
Neonatal  Tolerance  (N-TOL) Induction.  Newborn  BI0.A  mice  (24-48  h  old)  were 
administered  a  single  dose  of 0.1  mg of HEL  in  0.05  ml  of a  saline  emulsion  with 
incomplete Freund's adjuvant (IFA) (Gibco Laboratories, Grand Island, NY), intraperi- 
toneally. Initially,  control mice received equivalent volumes of saline-IFA emulsion.  No 
difference was observed between control mice and untreated mice in response to HEL or 
its derivative peptide fragments in the T-dependent, lymph node cell proliferation assay. 
Subsequent experiments used untreated age- and sex-matched control mice. All neonatally 
tolerized mice were immunized at 8-16 wk of age; however, such mice remained tolerant 
to HEL challenge at >26 wk of age (data not shown). 
In Vivo Immunizations.  Mice were injected subcutaneously in each rear footpad with 
50 #g of lysozyme (3.5  nmol), or the molar equivalent for peptide  fragments (used as 
antigens for in  vivo immunization), in saline  emulsion with  complete Freund's adjuvant 
(CFA), containing 1 mg/ml Mycobacterium tuberculosis strain H37Ra (Difco Laboratories, 
Inc., Detroit, MI).  Immunizations with L2 and AP-HEL were performed with either 3.5 
or 0.35 nmol per footpad. Either of these doses will induce vigorous proliferative lymph 
node cell responses in the B 10.A mouse. 
Antigen-dependent  Lymph Node T Cell Proliferation  Assay.  The in vitro culture system 
used in this study was adapted with slight modification (26) from that of Corradin et al. 
(25).  Inguinal and popliteal lymph nodes were removed and single-cell  suspensions were 
made 9-11  d after subcutaneous immunization in each rear footpad. Lymph node cells 
were  washed  three  times  and  adjusted  to  4  X  106  viable  celis/ml  in  Click's medium, 
modified by the addition of Hepes (15 raM),  gentamycin sulfate (0.010 mg/mi), and the 
substitution of normal mouse serum (0.5%) for fetal calf serum. 4 x  10  ~ lymph node cells 
in 0.1  ml Click's medium was added to an equal volume of soluble antigen (for in vitro 
challenge) in Click's medium to yield a final  antigen concentration of 6.8 mM. Control 
cultures for unstimulated background proliferation received medium alone.  These cul- 
tures, in flat-bottom, 96-well microtiter plates (3040; Falcon Labware, Oxnard, CA), were 
incubated at 37°C in a humidified atmosphere of 2% CO2 in air for 5 d. DNA synthesis 
was  assessed  by  incorporation  of tritiated  thymidine  ([~H]TdR)  (6.7  Ci/mmol;  New 
England Nuclear, Boston, MA); 1 #Ci [SH]TdR was added to each culture for the last 20- 
22 h of culture. Cultures were harvested by a multiple automated sample harvester onto 
glass fiber filter  strips  (grade 934AH; Whatman,  Inc., Clifton,  NJ),  and discs  for each 
culture were immersed in 1 ml Aquasol (New England Nuclear) for scintillation  counting. 
Statistical  Treatment  of Data.  The  following experimental  design,  in  which  the  re- 
sponses of individual  mice were evaluated,  was selected  to avoid the problem of false 
positives,  which may result if a small number of break-through responses occur in a group 
of tolerant  mice  whose  cells  are  pooled  for  assay.  The  representation  of individual 
responses as a fraction of the mean of control responses was used to normalize responses, 
which can be variable in magnitude between experiments. This normalization was neces- 
sary to present the combined results of multiple experiments. Each experiment involved 
three  to  six  individuals  in  control  and  experimental  groups,  and  experiments  were 
repeated one or more times. 
Each experimental and control animal was individually assayed in the in vitro, antigen- 
specific,  T  cell-dependent, lymph node cell proliferation assay.  Arithmetic means were 
calculated for [~H]TdR incorporation of triplicate cultures of each individual.  Antigen- 
specific incorporation was determined by subtracting the mean incorporation of cultures 
that received medium alone from the mean incorporation of antigen-stimulated cultures. 
The  antigen-specific  incorporation  for  each  experimental  and  control  individual  was 
evaluated as a percentage of the mean response of the control group in each experiment. 
The histograms in  Figs.  2-5  represent  the arithmetic  mean  value of the experimental 
group expressed as a  percentage of the mean of the  untreated control responses.  The 
scattered  points  within  the  histograms  represent  the  spread  of individual  responses, 900  T  CELL  TOLERANCE:  SUPPRESSION  AND  CLONAL  DELETION 
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FIGURE  1.  HEL peptide probes used in this study.  See text for details. 
expressed as a percentage of the mean control  response, and are representative  of the 
variation between individual mice in this assay system. 
Results 
Peptide Probes of HEL Used in  this Study.  Previous studies in this laboratory 
with the  B10  mouse, a  genetic nonresponder to  HEL, demonstrated that Ts 
cell-inducing determinants (SD) in one region of HEL prevent the response of 
Th cells  directed against other determinants within the molecule. A mild acid 
hydrolysis fragment of HEL, the NC peptide (amino acid residues  1-17:cys 6- 
cys  127:120-129),  induces HEL-specific Ts  cells  that can  suppress  the entire 
subsequent response to HEL (22).  Despite this lack of response, peptide frag- 
ments derived from HEL (Fig.  1) could be used to demonstrate "latent" T  cell 
responsiveness to determinants within HEL in B10 mice. We obtained latent T 
cell proliferative responses, through removal of the dominant SD, to the largest 
product of cyanogen bromide cleavage, L2 (residues  13-105),  and even to the 
aminopeptidase  product,  AP-HEL  [des-(1,2,3)-HEL].  This  localized  the  B10 
HEL-induced Ts activity to the "TIP" determinant, which contains, or is struc- 
turally influenced by, the amino-terminal tripeptide (23). 
The L2 (26) and AP-HEL (23)  derivatives can also be used as immuonogenic 
probes for HEL responder B10.A mice. The NC peptide is normally immuno- 
genic in B10.A mice (26) by virtue of determinants at residues 13-17 and 120- 
129. 2 Another cyanogen bromide cleavage fragment, L3 (residues  106-129), 
primes  for  a  vigorous proliferative response  in  the  B10.A  mice  that  can  be 
stimulated with either L3 or HEL in vitro. However, HEL immunization results 
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in a  response that hierarchically favors determinants  within  L2, with little  or no 
activation  of L3-specific  clones  (26).  Thus,  L3  should  represent  a  qualitatively 
distinct probe for latent responses in the HEL-tolerant B10.A. 
Experimental Scheme.  We used these peptide  fragments to examine  B10.A T 
cell responses under three conditions of HEL tolerance: (a) low dose (2 mg HEL) 
intravenous administration  into adult mice followed by immunization in 10-14  d 
[A-TOL(2 mg)], (b) neonatal (24-48 h  old) intraperitoneal  administration of 100 
tag HEL emulsified  in  IFA, followed by immunization  in 8-12  wk (N-TOL), (c) 
high  dose  (20  mg  HEL)  intravenous  injection  into  adult  mice  followed  by 
immunization in  10-14 d  [A-TOL(20 mg)]. The experimental  sequence, consist- 
ing of exposure of the putatively  tolerant  mice to immunogen  in vivo followed 
by restimulation  of activated  lymphocytes with antigen  or antigen peptide  frag- 
ments  in  vitro,  tests  the  efficacy of the  immunogen  for eliciting  proliferative 
responses in tolerized vs. untreated mice. The in vitro restimulation only assesses 
responses that have been activated during the in vivo immunization phase. 
Acute  HEL  Tolerance  in  Adult  BIO.A  Mice:  Latent  T  Cell  Responses  Can  Be 
Revealed by Immunization  With Peptide Fragments of HEL.  A  single  intravenous 
injection of 2  mg of HEL  in saline  induced a  profound  T  cell unresponsiveness 
to HEL  in adult  B10.A  genetic  responder  strain  mice,  as assessed  by a  T  cell- 
dependent  lymph node proliferation assay (Fig. 2). Such A-TOL(2 mg) mice also 
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FIGURE 2.  T cell tolerance to HEL induced in adult mice. BI0.A mice were tolerized  with 
2 mg HEL in saline [A-TOL(2 mg)], or sham-tolerized  with saline alone at 8-24 wk of age. 
These mice were immunized  with HEL or reduced, carboxymethylated HEL (RCM-HEL). 
Inguinal and popliteal lymph nodes were removed 9-11 d after immunization  and cultured as 
described in Materials and Methods (see text for details). Triplicate 0.2-ml suspension cultures 
were prepared with either medium alone (for unstimulated  background [ H]TdR incorpora- 
tion), or the antigens HEL or RCM-HEL at 7 ~M concentration for 5 d (in vitro challenge). 
Incorporation of [3HITdR was assayed during the last 18 h of culture. The arithmetic  mean 
[3H]TdR incorporation was calculated  for triplicate  cultures,  and the mean [SH]TdR incor- 
poration of unstimulated  cultures was subtracted to obtain the antigen-specific response  for 
each treated and sham-tolerized  mouse.  The arithmetic  mean antigen-specific  response  was 
calculated  for the sham-tolerized  control group, and is represented by the dashed horizontal 
line as the 100 value. The arithmetic mean antigen-specific response was calculated for the A- 
TOL(2 mg) group. This value was determined as a percentage of the mean antigen-specific 
response of the sham-tolerized control group, and is represented as a vertical bar. The antigen- 
specific response of each untreated control individual (O) was evaluated as a percentage of the 
mean response of the untreated control group. Similarly, the antigen-specific response of each 
A-TOL(2 mg) individual was evaluated as a percentage of the mean response of the untreated 
control group (O). The rationale for this representation is discussed in Materials and Methods. 902  T  CELL  TOLERANCE:  SUPPRESSION  AND  CLONAL  DELETION 
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FIGURE 3.  Latent responsiveness to HEL determinants can be revealed in acute, A-TOL(2 
rag)  mice by immunization with  L2 and L3  peptide fragments. A-TOL(2 mg) B10.A  mice 
were immunized with 3.5 nmol (equivalent to 50 pg of HEL) of L3 emulsified in CFA, or 
either 3.5 or 0.35 nmol of L2 (see Materials and Methods), and assayed as described in the 
legend for Fig. 2. The antigen-specific responses of sham-tolerized control individuals (0) and 
A-TOL(2  mg)  individuals (©)  are  represented as a  percent of the mean control response 
(---). A vertical bar represents the mean antigen-specific control responses of the A-TOL(2 
rag) group, as a percentage of the mean control response. 
were unresponsive to reduced and carboxymethylated HEL, demonstrating that 
the lack of response was evident for both native and denatured forms of HEL. 
To determine whether underlying T  cell responsiveness to epitopes within HEL 
remains  in  such acutely tolerized  B10.A  mice,  A-TOL(2  mg)  mice  were chal- 
lenged with L2 or L3 (Fig. 3). These peptides can induce a vigorous lymph node 
proliferation  in untreated B 10.A mice (26) that is completely crossreactive with 
the intact  HEL molecule.  The  L2 and  L3  fragments appear to span all  linear 
proliferation-inducing  determinants of HEL, since we were unable to induce T 
cell proliferation with L I (residues 1-12) in the B 10.A strain (unpublished data). 
Fig.  3  illustrates  that  latent  HEL  responsiveness  can  be  revealed  in  HEL  A- 
TOL(2 rag) mice by immunization with either L2 or L3 peptides. The responses 
to L2 and  L3 were directed at epitopes that are shared with  HEL and are not 
unique to these peptides, as evidenced by proliferative responses to HEL in vitro 
after peptide immunizations.  Although these latent responses were clearly signif- 
icant when compared with the lack of responses to HEL and reduced, carboxy- 
methylated HEL (RCM-HEL) in Fig. 3, it is noteworthy that the mean responses 
of acutely HEL-tolerized  B10.A  mice  to  L2 and  L3  represented  only 42 and 
57%, respectively, of untreated mean control responses with HEL in vitro, and 
50 and 71%, respectively, with the peptide fragments in vitro (see Results below, 
and Discussion). 
Therefore, in summary, the A-TOL(2 mg) treatment  induces an active regu- 
latory mechanism, presumably mediated by Ts cells, which does not permanently 
inactivate  all  T  proliferative  cells directed  against  other  portions  of the  HEL 
molecule.  Accordingly,  immunization  of these  HEL-tolerant  mice  can  evoke 
reactivity  to  peptides  lacking  SD.  These  results  have  led  to  experiments  that 
demonstrated the presence of Ts cells in A-TOL(2 rag) B10.A mice. 3 
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Acute HEL  Tolerance  in Adult BIO.A Mice: An  amino-terminal  Ts cell-inducing 
determinant  that  is  used  by  nonresponder  strain  H-2  b mice  is  also  used  by  HEL- 
tolerized  responder strain BIO.A mice.  The strong suggestion from the previous 
experiment was that a Ts cell, involving an L1 determinant, was responsible for 
A-TOL(2  rag) HEL  unresponsiveness.  In the following experiments,  two HEL 
derivatives were used for the attempted immunization of HEL-tolerant animals. 
These  derivatives were chosen to specifically  test the possibility that the major 
SD for the B 10.A strain might lie within the same region as had been shown for 
B10  mice.  Fig.  4  shows the result of immunization  to NC and  AP-HEL  in  A- 
TOL(2 rag).  Despite the presence of immunogenic epitopes on the NC disulfide 
peptide,  immunization of A-TOL(2  rag) mice with this peptide did not result in 
a proliferative response. This indicated that an SD exists on the NC peptide that 
does not permit expression of reactivities  to any other attached epitopes.  Thus, 
as  in  the  B10  mouse,  the  reactivity  to  L2  and  L3,  but  not  NC,  localizes  the 
dominant  SD  in  HEL-tolerant  B10.A  mice  to that  region  of NC  which  is not 
overlapped by L2 or L3, i.e., residues  1-12 (L 1 fragment). 
To  further  investigate  the  Ts-inducing  antigenic  requirements  in  the  N- 
terminal region  of HEL,  A-TOL(2  rag) B10.A  mice were challenged  with AP- 
HEL (residues 4-129).  AP-HEL retains secondary structure through four disul- 
fide linkages (see  Fig.  1), and possesses the tertiary structure of the intact HEL 
molecule, as evidenced by its undiminished enzymatic activity and its crossreac- 
tivity with almost all of the 50 anti-HEL monoclonal antibodies we have tested. 
This minimal alteration of HEL was sufficient to preclude the activation of B10 
Ts cells (23).  Remarkably,  in this tolerance  context, AP-HEL  induced a  prolif- 
erative response in a large proportion of acutely HEL-tolerant  B10.A mice and 
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FIGURE  4.  Low  dose  acute  tolerance  in  adult  BI0.A  mice:  an  amino-terminal  Ts  cell- 
inducing  determinant  is used  by  A-TOL(2  mg)  BI0.A  mice.  Latent  responsiveness  to  HEL 
determinants could be revealed by immunization with AP-HEL but not with NC. This indicated 
that the amino-terminal  tripeptide, present in NC and absent in AP-HEL, is important for the 
expression  of HEL-induced  suppression.  A-TOL(2  rag)  B10.A  mice  were  immunized  with 
either 3.4 or 0.34 nmol of AP-HEL (see Materials and Methods), or with 3.4 nmol of NC, and 
assayed as described in the legend for Fig. 2. The antigen-specific  responses of sham-tolerized 
control  individuals (0) and A-TOL(2  mg) individuals ((3) are represented  as a  percent  of the 
mean control  response  (---).  The  graphic representation  is described  in the legends to Figs. 
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TIP determinant is the major Ts-inducing HEL element in the A-TOL(2  rag) 
B10.A mouse as well as in the B10 nonresponder strain. 
Neonatal  HEL  Tolerance:  No  Latent  T  Cell  Response  Could  Be  Revealed  by 
Immunization  with  HEL  Fragments.  A  single  intraperitoneal  injection,  at  24- 
48 h  of age, of 0.1  mg HEL emulsified in IFA induced unresponsiveness at the 
level of T  cell proliferation to immunization with intact HEL at 8-24 wk of age 
(Fig. 5). No proliferative reactivity was revealed in response to either L2 or L3, 
whether intact HEL or the relevant peptide fragments were used for the in vitro 
stimulation (Fig.  5).  The  inability of these  mice  to  respond  to  the  L2  or  L3 
peptide is consistent with a  model of functional clonal deletion of all lysozyme- 
specific clones in  the neonatal environment.  If Ts  were  involved,  they would 
have to be specific for subdominant SD within L2 and L3, which may gain special 
access to Ts precursors within the neonatal milieu. 
High  Dose Acute  HEL  Tolerance:  Loss  of L2  Reactivity,  But  Retention  of L3 
Reactivity.  Administration of a single intravenous injection of 20 mg of HEL in 
saline negated subsequent B10.A T  cell proliferative responses to HEL (Fig. 6). 
Interestingly, as in the neonatal tolerance situation, and.in contrast to A-TOL(2 
mg)-induced tolerance, no latent T  cell responses could be revealed when high 
dose-tolerized mice were challenged with L2. This suggests that clonal deletion 
or anergy was induced in  the L2-reactive T  cell population that is exposed to 
high doses of HEL. However, unlike the results in neonatal tolerance, significant 
L3-induced responses remained after high dose tolerance. This may reflect the 
inefficient presentation  of L3  determinants  for  clonal  deletion  with  HEL  as 
toleragen, just as  L3 epitopes are  ineffectively presented as immunogens with 
HEL in the B10.A (26; see Discussion). 
Alternatively, the differential responsiveness to L2 in A-TOL(2  rag) and A- 
TOL(20 mg) mice may reflect a  hierarchy in the efficiency of Ts cell-inducing 
determinants in  HEL, with a  dominant SD at the amino terminus and one or 
more  subdominant  SD  within  L2.  The  TIP  SD  could  effectively induce  the 
dominant Ts in A-TOL(2 rag) mice. Subdominant SD within L2, which do not 
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FIGURE 5.  Neonatal HEL tolerance: no latent T  cell responses can be revealed by immuni- 
zation with HEL fragments. Neonatal B10.A mice (24-48 h old) were injected intraperitoneally 
with  100  ttg of HEL, emulsified in IFA. Control mice received saline emulsified in IFA, or 
were untreated: no difference was detected between these protocols. Mice were immunized at 
12-24 wk of age with HEL, L2, or L3, and assayed as described in the legend to Fig. 2. The 
antigen-specific  responses of sham-tolerized control individuals (0) and N-TOL individuals (O) 
are represented as a percent of the mean control response (---). The graphic representation 
is described in the legends to Figs. 2 and 3. OKI  AND  SERCARZ  905 
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FIGURE 6.  High  dose  acute  HEL  tolerance:  loss  of  L2  reactivity,  but  retention  of  L3 
reactivity.  Adult  B10.A  mice  were  injected  retroorbitally with  20  mg  HEL  in  saline [A- 
TOL(20 mg)] or saline alone (controls). Mice were immunized 10-14 d  later with HEL, L2, 
or L3, and assayed as described in legend to Fig. 2. The antigen-specific responses of sham- 
tolerized  control  individuals (0)  and  A-TOL(20  rag)  individuals (O) are  represented  as  a 
percent of the mean control response (---). The graphic representation is described in the 
legends to Figs. 2 and 3. 
toleragen concentrations, thus accounting for the loss of responsiveness to L2 in 
A-TOL(20 mg) mice. Furthermore, a suboptimal activation of L2-specific Ts in 
A-TOL(2  rag)  mice  may account  for  the  partial  suppression  of  L2-induced 
responses seen in  Fig.  3.  In this case, the resistance of L3-specific responses to 
A-TOL(2  mg) and  A-TOL(20  mg) treatment suggests the absence of an  SD 
within this fragment, or it may reflect a very inefficient L3 SD that gains optimal 
expression only in the neonatal milieu. 
Discussion 
The rationale for our using peptide fragments of protein toleragens as probes 
for latent T  cell responsiveness in  tolerant mice derives from the finding that 
antigenic determinants that  are recognized by Ts and Th/p  are distinct and 
nonoverlapping in several protein antigen systems (20). The amputation of a Ts- 
inducing determinant (SD) away from Th/p cell-inducing determinants releases 
the Th/p  clones from Ts  regulation,  thus revealing latent responses to those 
derivatives  lacking  the  SD.  In  the  B10  nonresponder  mouse,  the  prototype 
amputation experiment had been performed earlier (21,  23), giving rise to the 
notion that a single Ts cell-inducing determinant existed at the amino terminus 
of HEL for this haplotype. Study of HEL-induced tolerance in the B10.A mouse 
promised  to  be  especially interesting,  owing  to  a  number  of distinct  T  cell 
proliferation-inducing determinants within the molecule (26), coupled with the 
availability of several immunogenic peptide probes (L2, L3, NC, and AP-HEL), 
which allowed the differential analysis of the effects of three toleragenic regimens 
on these responses. Another advantage of this experimental design is the ability 
to study the induction of tolerance in  the in  vivo setting, at  the determinant 
level. 
This approach  has disclosed three distinct  states of unresponsiveness in  re- 
sponder  B10.A  mice  that  have  been  tolerized  to  HEL.  Superficially,  these 
tolerant states are identically manifested by Tp cell unresponsiveness to the intact 
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latent responsiveness to two fragments of HEL: (a)  low dose, acutely tolerized 
mice can respond to L2 and L3, (b) neonatally tolerized mice fail to respond to 
either L2 or L3, (c) high dose, acutely tolerized mice can respond to L3 but have 
lost the potential to respond to L2. These findings suggest that HEL unrespon- 
siveness results through distinct mechanisms in each  tolerant state.  As several 
investigators have recently noted (3-6), multiple pathways of tolerance induction 
must exist to insure the integrity of the organism, considering the heterogeneity, 
both qualitatively and quantitatively, of self molecules. 
Low Dose Acute  Tolerance: Suppression  Induced by a Dominant Determinant at the 
Amino Terminus of Lysozyme.  The analysis of acute low dose tolerance illustrates 
the efficacy of the SD amputation approach. The A-TOL(2 mg) B10.A mouse 
did not respond to  HEL or  NC.  The existence of latent responsiveness to  L2 
and L3 establishes that an active suppression mechanism occurs in the  B10.A 
strain to  lysozyme: previously, Ts had not been  examined in this strain.  The 
latent responses also rule out clonal deletion mechanisms in the nonresponsive- 
hess to HEL in A-TOL(2 nag) mice, except possibly to explain the lack of maximal 
L2, L3, and AP-HEL responses. The fact that A-TOL(2 mg) mice responded to 
AP-HEL suggests that a single dominant SD exists at the amino terminus of HEL 
in  the  B10.A  as  well as  in  the  B10  nonresponder. This is the first report  of 
apparently identical  SDs  in  nonresponder and  responder strain  H-2-congenic 
mice. This surprising finding implies a  common mechanism for restricted SD 
specificity, and one which possibly involves a non-H-2 genetic component. Strain 
survey experiments are  currently under way to test the interesting possibility 
that the TIP epitope may play an important role in suppressor induction in a 
wide  range  of haplotypes,  as  a  possible  "universal" and  dominant SD  in  the 
species which may be linked to naturally occurring immune tolerance to a  self 
antigen, such as routine lysozyme or lactalbumin. 
The normal B 10.A proliferative response to HEL is largely directed at deter- 
minants within L2, one of which crossreacts with NC (26) because of the overlap 
of residues 13-17. Other dominant HEL T  proliferation-inducing determinants 
may exist within L2, but remain to be identified in the B10.A. The inability of 
A-TOL(2 mg) mice to respond to the residues 13-17 and 120-129 determinants 
after  NC  immunization, or  to  all  L2  determinants after  HEL immunization, 
presumably  reflects  antigen-bridging  mechanisms  operative  between  the  Ts- 
directed  towards  TIP  and  the  Tp  cells  directed  towards  the  immunogenic 
determinants. 
The presence of Ts in A-TOL(2 rag) B10.A  lymph nodes has been demon- 
strated by classical  in vitro mixing experiments, but these experiments require 
manipulations to remove augmenting T  cells  that coexist in these populations 
and mask the Ts activity in vitro.  ~ Study of the cell  types that exist in  the A- 
TOL(2 mg) B 10.A mouse indicate the presence of both Lyt-2  + Ts effector cells 
and Lyt-1 + Ts inducer cells as well as Lyt-l+,2  + T  augmenting cells.  Therefore, 
the presence  of active Ts  that can ablate  normal T  cell  help for an  antibody 
response can be directly demonstrated in the B10.A mouse. This work strength- 
ens and broadens the scope of the tolerance experiments presented in this paper 
at the level of the Tp cell. 
Neonatal  Tolerance:  Evidence for  Clonal Deletion.  When  tolerance is acutely 
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system with existing capacity for complex effector and regulatory functions in 
response to antigenic challenge. T  cell unresponsiveness may result from ampli- 
fication of the  Ts  circuitry,  which  is  a  regulatory component of the  normal 
response to antigen (10,  11,27). Alternatively, it may result from inactivation of 
mature effector precursor or inducer cells by a tolerogenic signal, either in the 
form of nominal antigen or,  more likely, antigen in the context of MHC gene 
products.  In contrast, neonatally induced tolerance initially acts upon a  devel- 
opmentally immature immune system that is deficient in peripheral Ia expression 
and poor in accessory function (28-30).  However, the toleragenic stimuli must 
continue to  impinge upon  the maturing system as effector precursors emerge 
from the stem cell pool. 
We investigated the HEL peptide-induced proliferative response potential of 
neonatally tolerized  mice  in  an  attempt  to  compare  the  neonatally induced 
unresponsive state with both acutely induced tolerance and the prototype case 
of the genetic nonresponder. Interestingly, our initial attempts to induce neonatal 
tolerance with soluble antigen at high doses failed, but a single 24-48 h postnatal, 
imraperitoneal  injection of 0.1  mg of HEL in  emulsion  with  IFA effectively 
induced T  cell  proliferative unresponsiveness, which  remained evident for at 
least  180  d  (unpublished  data).  This  contrasts  with  the  relatively short-lived 
unresponsiveness of acute adult tolerance, induced by intravenous injection of 
HEL  in  solution,  which  begins  to  break  at  ~35  d.  It  also  demonstrates the 
toleragenic efficacy of small quantities of antigen when released slowly from an 
oil emulsion reservoir during postnatal maturation. Continued low level presence 
of antigen may be required for chronic stimulation of Ts cells or may be required 
to functionally delete emerging effector precursor populations as they differen- 
tiate from stem cells and express receptors for recognition of antigen plus Ia. 
Further differences between neonatal and acute adult tolerance are evident 
when responses to the HEL peptides are compared.  Unlike either low dose or 
high dose acute tolerance, no responsiveness was observed in neonatally HEL- 
tolerized mice challenged with L2 or L3 peptides. Two facts, that only a single 
Ts determinant is evident in the acute low dose-tolerant mouse, and that  L3 
responsiveness is resistant to even a 20 mg acute toleragenic challenge with HEL 
(Fig. 6), indicate that neonatally induced unresponsiveness to HEL determinants, 
induced and presumably maintained by slow  release of HEL, is mechanistically 
distinct from the acute tolerance states of adults. The  loss of responses to all 
HEL determinants is consistent with a model of functional deletion of specific T 
cell clones in neonatal tolerance and contrasts with the Ts-mediated unrespon- 
sivenessofacute  low dose tolerance in the adult, or the situation in the genetic nonre- 
sponder B 10 mouse. 
High Dose Acute Tolerance: A  Hierarchy of Tolerance Induction.  Analysis of 
latent responsiveness in the high dose (20 mg HEL) acute tolerance model led 
to a  surprising "split tolerance" result.  Tolerance to  L3  was  more difficult to 
induce than to L2 determinants because, even at this higher dose, L3 was able 
to elicit a response in the HEL-tolerant mouse. This becomes more understand- 
able in the context of the dominance of L2 determinants over L3 determinants 
when HEL is presented as immunogen (26);  L3 essentially is silent (0-20%  of 
tile maximal proliferation with HEL or L2). In contrast, L3 immunization induces 
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These results suggest that processing of intact HEL by antigen-presenting cells 
favors presentation of L2, thus skewing the response towards L2-specific reactiv- 
ity at  a  critical  inductive  phase  of the  response.  After  L3  immunization,  the 
lower level of L3 presentation with HEL in vitro may still  be sufficient to drive 
the in vitro proliferative response. Thus, if it is assumed that antigen recognition 
by T  cells does not fundamentally differ, whether the recognition leads to T  cell 
activation  or deletion,  the favored susceptibility of L2-specific clones to clonal 
deletion over L3-specific clones would follow from favored presentation  of L2 
over  L3  determinants  at  higher  doses of HEL-induced  acute  tolerance.  This 
assumption  is  supported  by the  recent  demonstration  that  T  cell  tolerance  is 
MHC  restricted  (31,  32) and  the  fact  that  acute  functional  clonal  deletion  in 
vitro is inhibitable by anti-MHC class II antibody (33). A prediction of the clonal 
deletion mechanism  is that  L3-reactive clones would be tolerized under condi- 
tions in which L3 could be presented efficiently to delete developing precursor 
T  cells.  Possibly,  the  L3-induced  responses  would be  negated  if even  higher 
doses of HEL, or high doses of L3, were used for acute tolerance induction. 
Potential Subsidiary Ts-inducing Determinants in L2 and L3.  Up until now, we 
have assumed that the only SD on HEL occurs at the TIP epitope in the B 10.A 
mouse, as in the nonresponder B10. However, it is possible that other SDs may 
exist within the L2 and L3 fragments.  The differential responsiveness to HEL, 
L2, and L3 in the three tolerant states examined may result from differences in 
efficiency of Ts induction by distinct SDs within HEL. The TIP SD is evidently 
dominant  to putative SDs within  L2, which,  in turn,  may be dominant  to SDs 
within L3, similar to the "hierarchical"  dominance of L2 determinants  over L3 
determinants for induction of proliferative responses. A possible mechanism may 
be a  differential processing of distinct regions in lysozyme, or differential asso- 
ciation  of  these  determinants  with  antigen  presentation  structures  that  are 
important in T  cell recognition events. 
Thus,  the TIP SD is the only SD that optimally induces Ts in A-TOL(2 mg) 
mice. The putative, subdominant SDs within  L2 may only be engaged at higher 
toleragen concentrations, and might account for the loss of L2 responsiveness in 
A-TOL(20 mg) mice. Furthermore,  a low level of activation of L2-specific Ts in 
A-TOL(2  mg)  mice  may  account  for  the  submaximal  L2-induced  responses 
depicted in Fig. 3. Similar arguments can be made for the submaximal responses 
induced by L3 shown in Figs.  3 and 6. However, the resistance of L3 responses 
to A-TOL(2 rag) and A-TOL(20 rag) treatments suggests the absence of an SD 
within this fragment.  Nevertheless, an alternative explanation to clonal deletion 
for the loss of L3 responses in N-TOL mice is that a subdominant SD within L3 
may gain expression in the neonatal milieu. 
"Minimal Peptide" Approach Towards Clarifying the Suppression/Deletion  Contro- 
versy.  Previous  experience  in  the  iysozyme and  ~8-galactosidase  (GZ)  systems 
indicates that  determinants  which address suppressor cells and helper cells are 
nonoverlapping  (21-23,  34).  This  implies  a  sequence-dependent  chemical  or 
structural  basis  for  the  distinction  of suppressor  and  helper  determinants.  A 
minimal Th/Tp-inducing determinant can be defined that requires the inclusion 
of both an agretope (35) (a site for association with an MHC molecule) and an 
epitope (a site for interaction  with the T  cell receptor).  It is unlikely that within 
a  stretch  of about  10 amino  acids,  regarded  as a  minimal  size  for a  complete OKI  AND  SERCARZ  909 
determinant as defined above, both a Th- and a Ts-inducing determinant would 
be  included.  Accordingly,  the  immune  status  of  responsiveness  to  minimal 
determinants such as that centralized at residues 13-17, or within T 11 (residues 
74-96) could be used to distinguish  whether suppression or clonal deletion, or 
conceivably a  combination  of these  mechanisms,  is  responsible  for  loss of re- 
sponses to L2 in neonatal or high dose, HEL-tolerized, B10.A mice. Studies with 
such minimal determinants are in progress in our laboratory. 
Summary 
Whether T  cell tolerance represents direct inactivation  of antigen-specific T 
cells via recognition of antigen plus major histocompatibility complex, or via T 
suppressor  (Ts)  cells,  or  a  combination  of these  mechanisms,  remains  to  be 
clarified.  This  problem was investigated  using a  novel approach  based on  the 
finding  in  several  systems  that  T  helper/proliferative  (Th/Tp)  cell-inducing 
antigenic  determinants  are  dissociable  from  Ts  cell-inducing  determinants. 
Thus,  peptide  probes  containing  known  sites  that  stimulate  T  proliferative 
activity,  as  well  as  peptides  from  distinct  sites  assumed  to  bear  Ts-inducing 
determinants,  were used in  studying hen  (chicken)  eggwbite lysozyme (HEL)- 
tolerant mice. The clear prediction  from clonal deletion models is that  Th/Tp 
response potential to short peptides in the tolerant mouse would not exist, while 
regulatory suppression  models predict  the coexistence of antigen-reactive  cells 
and antigen-specific regulatory cells that prevent their expression. 
Adult mice, treated with 2 mg HEL in saline, were tolerant to HEL in complete 
Freund's adjuvant (CFA). Latent T  cell proliferative responses could be revealed 
to  determinants  within  two  HEL  peptide  probes,  which  lacked  the  amino- 
terminal region of the molecule. This responsiveness suggested two conclusions: 
first, Ts cells directed against the amino terminus oflysozyme exist in the tolerant 
genetic responder  B10.A;  second,  these  Ts regulate  the  activity of functional 
antigen-reactive T  cells directed against epitopes elsewhere on the molecule, but 
only in the presence of the complete molecule, HEL. 
Examination of neonatally induced tolerance did not reveal any latent respon- 
siveness, supporting the hypothesis that clonal deletion or anergy is the relevant 
mechanism  in  this  situation.  Possible reservations  in  these explanations  of the 
two tolerant states, plus analysis of the more complex "split tolerance" resulting 
from 20 mg HEL in saline treatment in adults, are discussed. The approach of 
dissociation  of proliferation-inducing  determinants  from  suppression-inducing 
determinants clarifies our understanding of the tolerant state and holds promise 
for more definitive exploration of mechanisms of T  cell tolerance. 
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